-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
BEIJING, March 10, 2022 /PRNewswire/ -- Biositu (Beijing) Pharmaceutical Technology Co.
The fully human antibody mouse RenMice platform (RenMab® and RenLite®) was developed by Biositu over a period of 5 years using the self-developed super-segment chromosome engineering technology SUPCE
BeiGene is a global, science-based biotechnology company committed to being a game-changer in the global biopharmaceutical industry, focused on developing innovative, affordable medicines that improve outcomes and accessibility for patients around the world
Regarding this cooperation, Dr.
Dr.
Source: Biositu